News for hackers. Stuff that matters.
Re:Pancreatic cancer halted by virus injection in three pati... by mft_ on Friday November 20, 2026 @04:09AM (#50572077)
For such an approach to work, you need to be able to reliably select patients with the same prognosis for your two test groups. However, we’re not actually very good at being able to judge what you’re asking for (how close someone is to death in a quantitative manner) and not good at defining that in a way that can be applied by multiple investigators across multiple trial sites.

The typical approach for phase I trials is instead to select patients who have somehow exhausted all standard available treatment options. However, there is often a requirement that trial subjects aren’t as close to death as you propose, as the trial needs to observe patients for safety events as much as possible, even in cases where they aren’t receiving much benefit.

Re:Pancreatic cancer halted by virus injection in three pati... by nutjob2 on Friday November 20, 2026 @02:01PM (#50580018)
It's not closeness to death I'm thinking of, it's lowest chance of remission. Admittedly they may be closely related.

The idea that you can't otherwise avoid death means all other factors won't have much, or any effect, on the outcome.